UT Southwestern Medical Center

UT Southwestern is a premier academic medical center that integrates pioneering biomedical research with exceptional clinical care and education. The institution's faculty includes Nobel Prize winners and is committed to translating science-driven research quickly into new clinical treatments. They provide medical care in over 80 specialties, serving more than 105,000 hospitalized patients, nearly 370,00 example emergency room cases, and oversee approximately 3 million outpatient visits a year. The institution's focus is on promoting health and a healthy society that enables the achievement of full human potential. They strive for excellence, innovation, teamwork, and compassion in all they do. UT Southwestern's research expenditures have grown significantly over the years, with about 5,800 projects funded by federal agencies, foundations, individuals and corporations. The institution has clinical training hospitals with a total of around 2347 beds.

100%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This news site is known for its high journalistic standards. It strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. It has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

100%

Examples:

No current examples available.

Conflicts of Interest

100%

Examples:

No current examples available.

Contradictions

100%

Examples:

No current examples available.

Deceptions

100%

Examples:

No current examples available.

Recent Articles

  • Semaglutide: A Game-Changer in Weight Loss and Heart Health for Individuals with Cardiovascular Disease - SELECT Trial Results

    Semaglutide: A Game-Changer in Weight Loss and Heart Health for Individuals with Cardiovascular Disease - SELECT Trial Results

    Broke On: Sunday, 23 June 2024 Semaglutide, a weight-loss drug marketed as Wegovy or Ozempic, significantly reduces major adverse cardiovascular events (MACEs) by 20% for individuals with overweight or obesity and cardiovascular disease. The SELECT trial revealed that semaglutide users sustained weight loss for up to four years, dropped an average of 10% of their body weight, and showed improvements in heart health regardless of the amount lost. Semaglutide's benefits held up for all subgroups and normal A1c levels at baseline.